The growing demand for precise immunological research and therapeutic development has spurred significant improvements in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using various expression systems, including prokaryotic hosts, animal cell lines, and viral